Why is Metropolis Healt falling/rising?

As of 18-Jul, Metropolis Healthcare Ltd is currently priced at 1,938.60, reflecting a decrease of 10.6 points or 0.54%. The stock has been experiencing a consecutive decline over the last two days, resulting in a total drop of 2.18% during this period. Despite this recent downturn, the stock has shown positive performance over the past week and month, with returns of 2.93% and 13.43%, respectively. However, it is noteworthy that the stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally upward trend prior to the recent decline. Additionally, the stock has seen a significant drop in delivery volume, which fell by 65.56% against the 5-day average, suggesting a decrease in investor participation. On a positive note, the company boasts high management efficiency with a return on capital employed (ROCE) of 26.87%, a low debt-to-equity ratio, and substantial institutional holdings at 45.58%, which may provide some support for the stock.
In the broader market context, Metropolis Healthcare's short-term performance has outpaced the benchmark Sensex, which has declined by 0.90% over the same week. However, the stock's year-to-date performance shows a decline of 6.05%, contrasting with the Sensex's gain of 4.63%, indicating that while the stock has performed well recently, it has struggled to maintain momentum over a longer period. The overall market sentiment may be affecting investor confidence, contributing to the recent decline in the stock price despite its strong fundamentals and management efficiency.